← Back to Search

Behavioral Intervention

Wellness Intervention for Smoking Cessation in Veterans with HIV (WISH Trial)

N/A
Waitlist Available
Led By Kristina Crothers, MD
Research Sponsored by Seattle Institute for Biomedical and Clinical Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
HIV+ serostatus
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3, 6, 12 months post-randomization
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare an HIV-specific wellness intervention to standard care (referral to national VA Quitline and SmokefreeVET texting program) to see which is more effective.

Who is the study for?
This trial is for veterans living with HIV who smoke at least 5 cigarettes a day, are in VA care, can text, and speak English. It's not for those with hearing/comprehension issues, institutionalized individuals, people with severe cognitive impairments, pregnant women or anyone already getting help to quit smoking.
What is being tested?
The study compares a wellness intervention tailored for smokers with HIV against standard services like the National VA Quitline and SmokefreeVET texting. Participants also have access to quitting medications through their VA healthcare providers.
What are the potential side effects?
Since this trial focuses on behavioral interventions rather than medication, direct side effects from the interventions are minimal. However, participants may experience stress or anxiety related to attempting to quit smoking.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am HIV positive.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3, 6, 12 months post-randomization
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3, 6, 12 months post-randomization for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
7-day point-prevalence abstinence (PPA)
Any 24-hour intentional quit attempt
Secondary study objectives
30-day self-report point-prevalence abstinence (PPA)
7-day self-report point-prevalence abstinence (PPA)
Absolute CD4 count
+9 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention - Wellness Intervention for Smokers with HIVExperimental Treatment1 Intervention
The experimental WISH intervention is an HIV-specific comprehensive wellness program designed to offer integrated phone and text counseling regardless of readiness to quit.
Group II: Control - Standard CareActive Control1 Intervention
The control intervention is referral to standard evidence-based cessation services available nationally to Veterans, including the National VA Quitline and SmokefreeVET texting program.

Find a Location

Who is running the clinical trial?

Seattle Institute for Biomedical and Clinical ResearchLead Sponsor
54 Previous Clinical Trials
13,475 Total Patients Enrolled
Kaiser PermanenteOTHER
554 Previous Clinical Trials
27,731,528 Total Patients Enrolled
University of California, DavisOTHER
945 Previous Clinical Trials
4,755,914 Total Patients Enrolled

Media Library

Wellness Intervention for Smokers with HIV (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04505371 — N/A
Human Immunodeficiency Virus Infection Research Study Groups: Intervention - Wellness Intervention for Smokers with HIV, Control - Standard Care
Human Immunodeficiency Virus Infection Clinical Trial 2023: Wellness Intervention for Smokers with HIV Highlights & Side Effects. Trial Name: NCT04505371 — N/A
Wellness Intervention for Smokers with HIV (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04505371 — N/A
~36 spots leftby Aug 2025